During the past decade, Gynecologic Oncology of Indiana conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gynecologic Oncology of Indiana" #1 collaborator was "NRG Oncology" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Gynecologic Oncology of Indiana" are "Cervical Adenocarcinoma" (2 trials), "Cervical Squamous Cell Carcinoma" (2 trials), "Cervical Adenosquamous Carcinoma" (1 trials), "Cervical Adenosquamous Cell Carcinoma" (1 trials) and "Recurrent Cervical Carcinoma" (1 trials). Many other conditions were trialed in "Gynecologic Oncology of Indiana" in a lesser frequency.

Most popular intervention types in "Gynecologic Oncology of Indiana" are "Drug" (4 trials), "Biological" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Cisplatin" (2 trials), "3-Dimensional Conformal Radiation Therapy" (1 trials), "Conventional Surgery" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gynecologic Oncology of Indiana" are 5 trials for "Female" genders.

Currently, there are NaN active trials in "Gynecologic Oncology of Indiana". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Gynecologic Oncology of Indiana, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Gynecologic Oncology of Indiana, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".